Reviva Pharmaceuticals Holdings, Inc.

NASDAQ:RVPH

0.7824 (USD) • At close April 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -29.919-39.261-24.339-8.522-3.783-0.847-1.68
Depreciation & Amortization 00000.0010.0010.018
Deferred Income Tax 0000000
Stock Based Compensation 1.633.4130.1770.107000.021
Change In Working Capital -4.5387.2845.007-0.702-2.330.6340.542
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 2.2910.3293.011-0.4980.7750.1580
Other Working Capital -6.8296.9551.997-0.204-3.1050.4760.542
Other Non Cash Items -0.7180.2390.195-1.5512.387-0.0060.028
Operating Cash Flow -33.544-28.324-18.961-10.668-3.726-0.218-1.071
Investing Activities:
Investments In Property Plant And Equipment 0000000
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow 0000000
Financing Activities:
Debt Repayment 0.458000000
Common Stock Issued 23.19427.4947.77431.497000
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 05.6780.0190.09812.82700.175
Financing Cash Flow 23.65333.1727.79231.59612.8270.10.175
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -9.8914.848-11.16820.9278.76-0.1180.119
Cash At End Of Period 13.47623.36718.5229.6888.7600.119